{"id":7917,"date":"2026-10-14T21:00:00","date_gmt":"2026-10-14T13:00:00","guid":{"rendered":"https:\/\/nowserving.ph\/blog\/?p=7917"},"modified":"2026-10-14T18:34:40","modified_gmt":"2026-10-14T10:34:40","slug":"semaglutide-vs-tirzepatide","status":"publish","type":"post","link":"https:\/\/nowserving.ph\/blog\/semaglutide-vs-tirzepatide\/","title":{"rendered":"Semaglutide vs Tirzepatide: Difference Between These Weight Loss Medications"},"content":{"rendered":"\n

Semaglutide and tirzepatide are two prescription medicines doctors use for type 2 diabetes and, for some patients, weight management. They work in similar ways, but they are not the same. This guide explains how each one works, where they differ, and how to talk to a doctor about whether either fits you..<\/p>\n\n\n\n

What are Semaglutide and Tirzepatide?<\/strong><\/h2>\n\n\n\n

Before weighing semaglutide vs tirzepatide, start with what each one is. Both copy incretins, the gut hormones your body releases after a meal to help manage appetite and control blood sugar. In the Philippines, both are registered as prescription drugs, which you can confirm on the FDA Philippines verification portal<\/a>.<\/p>\n\n\n\n

Semaglutide: A GLP-1 Receptor Agonist<\/strong><\/h3>\n\n\n\n

As a GLP-1 receptor agonist, semaglutide acts like glucagon-like peptide-1 (GLP-1), a natural hormone that signals fullness and helps the pancreas release insulin when blood sugar rises. It belongs to a medicine class called incretin mimetics, the same class as tirzepatide. In the Philippines, semaglutide is registered for type 2 diabetes (as an injection or a tablet), for weight management in adults and teens 12 and older, and, in adults with type 2 diabetes and heart disease, to lower the risk of heart attack and stroke. <\/p>\n\n\n\n

\"two<\/figure>\n\n\n\n

In the US, it is also approved to lower heart risk in adults with obesity and to slow kidney disease in some adults with type 2 diabetes.<\/p>\n\n\n\n

Tirzepatide: A Dual GIP and GLP-1 Receptor Agonist<\/strong><\/h3>\n\n\n\n

Unlike semaglutide, tirzepatide acts on two hormone receptors. Besides GLP-1, it activates the receptor for glucose-dependent insulinotropic polypeptide (GIP), another gut hormone involved in insulin release. In the Philippines, tirzepatide is registered for type 2 diabetes and for weight management in adults.<\/p>\n\n\n\n

In the US, it is also approved for obstructive sleep apnea in adults with obesity. It is given as an injection under the skin.”<\/p>\n\n\n\n

How These Gut Hormones Work in Your Body<\/strong><\/h2>\n\n\n\n

Every time you eat, your gut sends hormone signals to your brain and pancreas. Semaglutide and tirzepatide strengthen these signals in three main ways.<\/p>\n\n\n\n

\"control<\/figure>\n\n\n\n

Appetite and Food Intake<\/strong><\/h3>\n\n\n\n

Each medicine acts on appetite centers in the brain, and targets your hunger so you feel full sooner and stay full longer. This tends to lower food intake without a constant fight against insatiation.<\/p>\n\n\n\n

Some people also talk about “food noise,” the constant background thoughts about eating. Researchers are still studying how these medicines affect it, and whether either one quiets food noise more than the other is not settled.<\/p>\n\n\n\n

Gastric Emptying<\/strong><\/h3>\n\n\n\n

These medicines also slow gastric emptying, meaning food leaves your stomach more slowly. Because sugar from a meal enters the blood more gradually, slower emptying also helps keep blood glucose levels steadier after you eat.<\/p>\n\n\n\n

Insulin Release and Blood Sugar Levels<\/strong><\/h3>\n\n\n\n

After a meal, these medicines prompt the pancreas to release insulin when blood sugar is high. This boost in insulin secretion depends on glucose, so the effect is strongest when blood sugar levels climb.<\/p>\n\n\n\n

Read this related article on <\/em><\/strong>GLP-1 drugs for weight management<\/span><\/em><\/strong><\/a> to learn how this class of medicines works.<\/em><\/strong><\/h4>\n\n\n\n

Semaglutide vs Tirzepatide: Key Differences<\/strong><\/h2>\n\n\n\n

The two medicines share a lot, including better glycemic control in type 2 diabetes, but they are not interchangeable. Here is where they differ most.<\/p>\n\n\n\n

\"clinical<\/figure>\n\n\n\n

Single Action vs Dual Action<\/strong><\/h3>\n\n\n\n

Animal studies link tirzepatide’s GIP side to better insulin sensitivity, which matters for people with insulin resistance. Human data on how much this dual action adds is still limited.<\/p>\n\n\n\n

Weight Reduction in Clinical Trials<\/strong><\/h3>\n\n\n\n

Each medicine has led to significant weight loss in clinical trials when paired with diet and exercise. In 2025, the first head-to-head trial in adults with obesity but without diabetes, the SURMOUNT-5 study in the New England Journal of Medicine<\/a>, found greater weight loss with tirzepatide.<\/p>\n\n\n\n

That trial was open-label and funded by the maker of tirzepatide, so doctors read it alongside other evidence. Average weight loss in a study also does not predict your own result, and not everyone sees significant weight loss on either medicine.<\/p>\n\n\n\n

Heart Disease Risk Reduction<\/strong><\/h3>\n\n\n\n

Semaglutide has a US approval to lower the risk of heart attack, stroke, and cardiovascular death in adults with established cardiovascular disease and obesity or overweight. It was the first weight management medicine to receive that approval, according to the US Food and Drug Administration<\/a>.<\/p>\n\n\n\n

NOTE: <\/em><\/strong>In the Philippines, semaglutide’s heart approval covers adults with type 2 diabetes and established heart disease. The US approval for adults with obesity is not on the Philippine label, so ask your doctor whether it applies to you.<\/em><\/p>\n\n\n\n

Consult a cardiologist on NowServing<\/strong><\/a> if you have heart disease or it runs in your family.<\/strong><\/p>\n\n\n\n

Cost Difference<\/strong><\/h3>\n\n\n\n

Tirzepatide generally costs more than semaglutide in the Philippines. In online pharmacy listings in October 2026, a lowest-strength semaglutide pen cost about PHP 7,600 to PHP 9,900, and a lowest-strength tirzepatide pen about PHP 10,800 to PHP 12,600. Higher strengths cost more.<\/p>\n\n\n\n

These are estimates only. Prices change often and vary by pharmacy, so ask your pharmacist for a current price. Your doctor decides which medicine and strength fits you, if any.<\/p>\n\n\n\n

NOTE:<\/strong> Buy weight loss medicines only from an FDA-licensed pharmacy, with a valid prescription. Unregistered tirzepatide products sold online carry no assurance of quality, safety, or efficacy, according to an FDA Philippines public health warning<\/a>.<\/em><\/p>\n\n\n\n

Blood Sugar Control in Type 2 Diabetes<\/strong><\/h2>\n\n\n\n

Type 2 diabetes is the most common form of diabetes mellitus<\/a>, in which the body does not use insulin well. Semaglutide and tirzepatide both improve glycemic control by boosting insulin secretion when blood glucose levels rise after meals.<\/p>\n\n\n\n

Insulin resistance often comes with excess body weight, and over time it pushes blood sugar levels up. Lowering body weight can improve insulin sensitivity, which is why weight management and blood sugar control often share one treatment plan.<\/p>\n\n\n\n

On their own, these medicines seldom cause low blood sugar. The risk rises when they are taken with insulin or some other diabetes medications, so your doctor may adjust them. Know the signs of low blood sugar, such as shakiness, sweating, and dizziness, and tell your doctor if you notice them.<\/p>\n\n\n\n

Consult an endocrinologist on NowServing<\/strong><\/a> for diabetes-related doctor consultations.<\/strong><\/p>\n\n\n\n

Who Qualifies for Semaglutide and Tirzepatide<\/strong><\/h2>\n\n\n\n

Weight loss medications like semaglutide and tirzepatide are prescription-only. That means, your doctor will decide whether you are eligible to use these GLP-1 drugs. In the Philippines, doctors use the Asia-Pacific body mass index cutoffs. A BMI of 23 to 24.9 is considered overweight, and 25 and above is considered obesity. That’s just one of the factors that doctors consider.<\/p>\n\n\n\n

\"doctor<\/figure>\n\n\n\n

A doctor’s review also covers:<\/strong><\/p>\n\n\n\n